CAMLG antibody
Principal name
CAMLG antibody
Alternative names for CAMLG antibody
CAML, Calcium signal-modulating cyclophilin ligand
Ncbi ID
9606, NP_001736, NP_001736.1, NP_031622.2, NM_007596, NM_001745
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of CAMLG antibody
The immunosuppressant drug cyclosporin A blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. When bound to cyclophilin B, cyclosporin A binds and inactivates the key signaling intermediate calcineurin. CAMLG functions similarly to cyclosporin A, binding to cyclophilin B and acting downstream of the TCR and upstream of calcineurin by causing an influx of calcium. This integral membrane protein appears to be a new participant in the calcium signal transduction pathway, implicating cyclophilin B in calcium signaling, even in the absence of cyclosporin.The immunosuppressant drug cyclosporin A blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. When bound to cyclophilin B, cyclosporin A binds and inactivates the key signaling intermediate calcineurin. The protein encoded by this gene functions similarly to cyclosporin A, binding to cyclophilin B and acting downstream of the TCR and upstream of calcineurin by causing an influx of calcium. This integral membrane protein appears to be a new participant in the calcium signal transduction pathway, implicating cyclophilin B in calcium signaling, even in the absence of cyclosporin.
General readings
Nagano,J., (2005) Biochem. Biophys. Res. Commun. 338 (2), 880-889

















- Quick-Filters:
- Highly Validated (2)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA504329 | CAMLG antibody |
||||||
| CAMLG mouse monoclonal antibody, clone OTI1A3 (formerly 1A3) | |||||||
![]() |
Mouse | IgG1 | OTI1A3 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
+6 additional images |
Highly validated antibody! |
||||||
| TA504363 | CAMLG antibody |
||||||
| CAMLG mouse monoclonal antibody, clone OTI2H3 (formerly 2H3) | |||||||
![]() |
Mouse | IgG1 | OTI2H3 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+3 additional images |
Highly validated antibody! |
||||||
| TA504636 | CAMLG antibody |
||||||
| CAMLG mouse monoclonal antibody, clone OTI1H3 (formerly 1H3) | |||||||
![]() |
Mouse | IgG2b | OTI1H3 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP318292 | CAMLG |
||||
| Recombinant protein of human calcium modulating ligand (CAMLG) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR204041L2V | Lenti ORF particles, Caml (GFP-tagged) - Mouse calcium modulating ligand (Caml), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR204041L1V | Lenti ORF particles, Caml (Myc-DDK-tagged) - Mouse calcium modulating ligand (Caml), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||









+6 additional images



